封面
市场调查报告书
商品编码
1607936

心臟心律不整监测设备的全球市场:产业分析,规模,占有率,成长,趋势,预测(2024年~2031年)

Cardiac Arrhythmia Monitoring Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日期: | 出版商: Persistence Market Research | 英文 269 Pages | 商品交期: 2-5个工作天内

价格
简介目录

2024年全球心律不整监测设备市场规模预估为84.932亿美元,2024-2031年预测期间复合年增长率为7.80%,2031年将达到143亿美元。

心律不整监测设备是诊断和治疗心律不整的重要工具。这些设备用于追踪心律、检测异常并及时采取干预措施来控制心律不整。市场上有许多不同类型的设备,包括动态心电图 (ECG) 机和植入式心臟监视器,这些设备正在帮助医疗保健提供者改善患者治疗效果并监测心臟健康状况。

由于多种因素,包括心臟病患病率的上升、对心律不整的认识不断增强以及医疗技术的进步,全球心律不整监测设备市场正在强劲增长。更容易患心血管疾病的老化人口的增加,正在进一步加速市场需求。此外,医疗保健支出的增加、医疗基础设施的改善以及穿戴式健康监测设备的日益普及也极大地促进了市场的扩张。采用远距医疗和远端监测进行心律不整管理也在市场扩张中发挥关键作用,特别是在服务不足的地区。

心律不整监测设备市场提供了巨大的成长机会,特别是透过开发提供即时监测和数据共享功能的便携式和可穿戴设备。个人化医疗保健的日益增长的趋势,加上分析心律不整资料的人工智慧和机器学习的进步,将为监测设备的创新开闢新的途径。此外,设备製造商和医疗保健提供者之间越来越多的合作伙伴关係提供整合解决方案并增强患者护理,这为市场参与者提供了另一个充满希望的机会。

本报告提供全球心臟心律不整监测设备市场相关调查,提供各产品类型,各用途,各终端用户,各地区趋势,及加入此市场的主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场简介

第3章 心律不整监测设备市场观点

第4章 北美的心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年)

第5章 南美的心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年)

第6章 欧洲的心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年)

第7章 亚太地区的心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年)

第8章 中东·非洲的心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年)

第9章 竞争情形

  • 市场结构
  • 竞争仪表板
  • 企业简介(详细内容- 概要,财务,策略,SWOT,最近的趋势)
    • NUUBO Smart Solutions Technologies, SL
    • Koninklijke Philips N.V.
    • GE Healthcare (General Electric Company)
    • Welch Allyn - A Hill-Rom Inc. Company
    • Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
    • Nihon Kohden Corporation
    • Fukuda Denshi Co., Ltd.
    • Biotelemetry, Inc.
    • AliveCor, Inc.
    • Biotronik, Inc.
    • Medronic, Plc.
    • St. Jude Medical, LLC. (Abbott Laboratories)

第10章 全球心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年),各地区

第11章 全球心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年),各产品类型

第12章 全球心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年),各用途

第13章 全球心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年),各终端用户

第14章 全球心臟心律不整监测设备市场分析(2019年~2023年)及预测(2024年~2031年)

第15章 所使用的假设和缩写

第16章 调查手法

简介目录
Product Code: PMRREP12325

Persistence Market Research has recently released an in-depth report on the global market for cardiac arrhythmia monitoring devices. This comprehensive analysis provides valuable insights into key market dynamics, including growth drivers, trends, opportunities, and challenges. The research offers exclusive data and projections for the global cardiac arrhythmia monitoring devices market, outlining the expected growth trajectory from 2024 to 2031.

Key Insights:

  • Cardiac Arrhythmia Monitoring Devices Market Size (2024E): US$ 8493.2 Mn
  • Projected Market Value (2031F): US$ 14369 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7.80%

Cardiac Arrhythmia Monitoring Devices Market - Report Scope:

Cardiac arrhythmia monitoring devices are essential tools for diagnosing and managing irregular heartbeats. These devices are used to track heart rhythm, detect abnormalities, and provide timely interventions to manage arrhythmias. The market includes various types of devices such as Holter monitors, electrocardiogram (ECG) devices, and implantable cardiac monitors, serving healthcare providers to improve patient outcomes and monitor heart health.

Market Growth Drivers:

The global cardiac arrhythmia monitoring devices market is experiencing robust growth driven by several factors, including the increasing prevalence of heart diseases, rising awareness about arrhythmias, and advancements in medical technology. The growing geriatric population, which is more prone to cardiovascular conditions, further accelerates market demand. Additionally, the rise in healthcare expenditure, improved healthcare infrastructure, and increasing adoption of wearable health monitoring devices contribute significantly to the market's expansion. The adoption of telemedicine and remote monitoring for arrhythmia management also plays a pivotal role in expanding the market reach, especially in underserved regions.

Market Restraints:

Despite the positive growth outlook, the cardiac arrhythmia monitoring devices market faces challenges such as high device costs, particularly for advanced diagnostic tools, which may limit adoption in emerging markets. Regulatory hurdles and the need for compliance with stringent health and safety standards also pose barriers to market entry. Additionally, the lack of trained professionals in certain regions to operate and interpret the data from these devices may hinder the market's overall growth.

Market Opportunities:

The cardiac arrhythmia monitoring devices market offers significant growth opportunities, particularly through the development of portable and wearable devices that provide real-time monitoring and data sharing capabilities. The growing trend toward personalized healthcare, coupled with advancements in artificial intelligence and machine learning to analyze arrhythmia data, opens new avenues for innovation in monitoring devices. Furthermore, increasing partnerships between device manufacturers and healthcare providers to offer integrated solutions and enhance patient care represents another promising opportunity for market players.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global cardiac arrhythmia monitoring devices market?
  • Which device types and technologies are seeing the most adoption across different healthcare settings?
  • How are advancements in AI and telemedicine reshaping the competitive landscape of the cardiac arrhythmia monitoring devices market?
  • Who are the key players in the market, and what strategies are they using to maintain competitive advantage?
  • What are the emerging trends and future prospects in the global cardiac arrhythmia monitoring devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global cardiac arrhythmia monitoring devices market, such as Medtronic, Abbott Laboratories, Boston Scientific, and Philips Healthcare, are focused on innovation, technological advancements, and strategic partnerships to strengthen their market positions. These companies invest in R&D to develop new monitoring devices that offer enhanced accuracy, portability, and ease of use. Collaborations with healthcare institutions and regulatory agencies are essential for ensuring compliance and gaining market acceptance. Additionally, the increasing focus on remote patient monitoring and the growing trend of home healthcare provide further opportunities for expansion and product diversification.

Key Companies Profiled:

  • NUUBO Smart Solutions Technologies, SL
  • Koninklijke Philips N.V.
  • GE Healthcare (General Electric Company)
  • Welch Allyn - A Hill-Rom Inc. Company
  • Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
  • Nihon Kohden Corporation
  • Fukuda Denshi Co., Ltd.
  • Biotelemetry, Inc.
  • AliveCor, Inc.
  • Biotronik, Inc.
  • Medronic, Plc.
  • St. Jude Medical, LLC. (Abbott Laboratories)

Market Taxonomy

By Product type

  • Implantable Cardiac Monitors
  • Resting ECG Devices
  • ECG Stress Test Devices
  • Mobile Cardiac Telemetry Monitors
  • Holter Monitors

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Homecare Settings
  • Long Term Care Centers
  • Emergency Medical Services

By Application

  • Atrial Fibrillation
  • Bradycardia
  • Conduction Disorders
  • Premature Contraction
  • Tachycardia
  • Ventricular Fibrillation

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Regulatory Scenario
  • 2.4. Pricing Analysis

3. Cardiac Arrhythmia Monitoring Devices Market View Point

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis
  • 3.3. Drivers
  • 3.4. Restraints
  • 3.5. Trends

4. North America Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 4.4.1. Implantable Cardiac Monitors
    • 4.4.2. Resting ECG Devices
    • 4.4.3. ECG Stress Test Devices
    • 4.4.4. Mobile Cardiac Telemetry Monitors
    • 4.4.5. Holter Monitors
  • 4.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 4.5.1. Implantable Cardiac Monitors
    • 4.5.2. Resting ECG Devices
    • 4.5.3. ECG Stress Test Devices
    • 4.5.4. Mobile Cardiac Telemetry Monitors
    • 4.5.5. Holter Monitors
  • 4.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 4.6.1. Atrial Fibrillation
    • 4.6.2. Bradycardia
    • 4.6.3. Conduction Disorders
    • 4.6.4. Premature Contraction
    • 4.6.5. Tachycardia
    • 4.6.6. Ventricular Fibrillation
    • 4.6.7. Others
  • 4.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 4.7.1. Atrial Fibrillation
    • 4.7.2. Bradycardia
    • 4.7.3. Conduction Disorders
    • 4.7.4. Premature Contraction
    • 4.7.5. Tachycardia
    • 4.7.6. Ventricular Fibrillation
    • 4.7.7. Others
  • 4.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 4.8.1. Hospitals
    • 4.8.2. Ambulatory Surgical Centers
    • 4.8.3. Diagnostic Centers
    • 4.8.4. Homecare Settings
    • 4.8.5. Long Term Care Centers
    • 4.8.6. Emergency Medical Services
  • 4.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 4.9.1. Hospitals
    • 4.9.2. Ambulatory Surgical Centers
    • 4.9.3. Diagnostic Centers
    • 4.9.4. Homecare Settings
    • 4.9.5. Long Term Care Centers
    • 4.9.6. Emergency Medical Services
  • 4.10. Drivers and Restraints: Impact Analysis
  • 4.11. Market Attractiveness Analysis
    • 4.11.1. By Country
    • 4.11.2. By Product Type
    • 4.11.3. By Application
    • 4.11.4. By End User
  • 4.12. Key Representative Market Participants
  • 4.13. Key Participants Market Presence (Intensity Map)

5. Latin America Cardiac Arrhythmia Monitoring Devices Market 2019-2023 and Forecast 2024-2031

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Rest of Latin America
  • 5.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 5.4.1. Implantable Cardiac Monitors
    • 5.4.2. Resting ECG Devices
    • 5.4.3. ECG Stress Test Devices
    • 5.4.4. Mobile Cardiac Telemetry Monitors
    • 5.4.5. Holter Monitors
  • 5.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 5.5.1. Implantable Cardiac Monitors
    • 5.5.2. Resting ECG Devices
    • 5.5.3. ECG Stress Test Devices
    • 5.5.4. Mobile Cardiac Telemetry Monitors
    • 5.5.5. Holter Monitors
  • 5.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 5.6.1. Atrial Fibrillation
    • 5.6.2. Bradycardia
    • 5.6.3. Conduction Disorders
    • 5.6.4. Premature Contraction
    • 5.6.5. Tachycardia
    • 5.6.6. Ventricular Fibrillation
    • 5.6.7. Others
  • 5.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 5.7.1. Atrial Fibrillation
    • 5.7.2. Bradycardia
    • 5.7.3. Conduction Disorders
    • 5.7.4. Premature Contraction
    • 5.7.5. Tachycardia
    • 5.7.6. Ventricular Fibrillation
    • 5.7.7. Others
  • 5.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 5.8.1. Hospitals
    • 5.8.2. Ambulatory Surgical Centers
    • 5.8.3. Diagnostic Centers
    • 5.8.4. Homecare Settings
    • 5.8.5. Long Term Care Centers
    • 5.8.6. Emergency Medical Services
  • 5.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 5.9.1. Hospitals
    • 5.9.2. Ambulatory Surgical Centers
    • 5.9.3. Diagnostic Centers
    • 5.9.4. Homecare Settings
    • 5.9.5. Long Term Care Centers
    • 5.9.6. Emergency Medical Services
  • 5.10. Drivers and Restraints: Impact Analysis
  • 5.11. Market Attractiveness Analysis
    • 5.11.1. By Country
    • 5.11.2. By Product Type
    • 5.11.3. By Application
    • 5.11.4. By End User
  • 5.12. Key Representative Market Participants
  • 5.13. Key Participants Market Presence (Intensity Map)

6. Europe Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 6.2.1. Germany
    • 6.2.2. U.K.
    • 6.2.3. France
    • 6.2.4. Italy
    • 6.2.5. Spain
    • 6.2.6. Poland
    • 6.2.7. Russia
    • 6.2.8. Rest of Europe
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 6.3.1. Germany
    • 6.3.2. U.K.
    • 6.3.3. France
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Poland
    • 6.3.7. Russia
    • 6.3.8. Rest of Europe
  • 6.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 6.4.1. Implantable Cardiac Monitors
    • 6.4.2. Resting ECG Devices
    • 6.4.3. ECG Stress Test Devices
    • 6.4.4. Mobile Cardiac Telemetry Monitors
    • 6.4.5. Holter Monitors
  • 6.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 6.5.1. Implantable Cardiac Monitors
    • 6.5.2. Resting ECG Devices
    • 6.5.3. ECG Stress Test Devices
    • 6.5.4. Mobile Cardiac Telemetry Monitors
    • 6.5.5. Holter Monitors
  • 6.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 6.6.1. Atrial Fibrillation
    • 6.6.2. Bradycardia
    • 6.6.3. Conduction Disorders
    • 6.6.4. Premature Contraction
    • 6.6.5. Tachycardia
    • 6.6.6. Ventricular Fibrillation
    • 6.6.7. Others
  • 6.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 6.7.1. Atrial Fibrillation
    • 6.7.2. Bradycardia
    • 6.7.3. Conduction Disorders
    • 6.7.4. Premature Contraction
    • 6.7.5. Tachycardia
    • 6.7.6. Ventricular Fibrillation
    • 6.7.7. Others
  • 6.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 6.8.1. Hospitals
    • 6.8.2. Ambulatory Surgical Centers
    • 6.8.3. Diagnostic Centers
    • 6.8.4. Homecare Settings
    • 6.8.5. Long Term Care Centers
    • 6.8.6. Emergency Medical Services
  • 6.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 6.9.1. Hospitals
    • 6.9.2. Ambulatory Surgical Centers
    • 6.9.3. Diagnostic Centers
    • 6.9.4. Homecare Settings
    • 6.9.5. Long Term Care Centers
    • 6.9.6. Emergency Medical Services
  • 6.10. Drivers and Restraints: Impact Analysis
  • 6.11. Market Attractiveness Analysis
    • 6.11.1. By Country
    • 6.11.2. By Product Type
    • 6.11.3. By Application
    • 6.11.4. By End User
  • 6.12. Key Representative Market Participants
  • 6.13. Key Participants Market Presence (Intensity Map)

7. Asia Pacific (APAC) Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 7.2.1. China
    • 7.2.2. India
    • 7.2.3. Japan
    • 7.2.4. Australia and New Zealand
    • 7.2.5. Rest of APAC
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 7.3.1. China
    • 7.3.2. India
    • 7.3.3. Japan
    • 7.3.4. Australia and New Zealand
    • 7.3.5. Rest of APAC
  • 7.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 7.4.1. Implantable Cardiac Monitors
    • 7.4.2. Resting ECG Devices
    • 7.4.3. ECG Stress Test Devices
    • 7.4.4. Mobile Cardiac Telemetry Monitors
    • 7.4.5. Holter Monitors
  • 7.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 7.5.1. Implantable Cardiac Monitors
    • 7.5.2. Resting ECG Devices
    • 7.5.3. ECG Stress Test Devices
    • 7.5.4. Mobile Cardiac Telemetry Monitors
    • 7.5.5. Holter Monitors
  • 7.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 7.6.1. Atrial Fibrillation
    • 7.6.2. Bradycardia
    • 7.6.3. Conduction Disorders
    • 7.6.4. Premature Contraction
    • 7.6.5. Tachycardia
    • 7.6.6. Ventricular Fibrillation
    • 7.6.7. Others
  • 7.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 7.7.1. Atrial Fibrillation
    • 7.7.2. Bradycardia
    • 7.7.3. Conduction Disorders
    • 7.7.4. Premature Contraction
    • 7.7.5. Tachycardia
    • 7.7.6. Ventricular Fibrillation
    • 7.7.7. Others
  • 7.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 7.8.1. Hospitals
    • 7.8.2. Ambulatory Surgical Centers
    • 7.8.3. Diagnostic Centers
    • 7.8.4. Homecare Settings
    • 7.8.5. Long Term Care Centers
    • 7.8.6. Emergency Medical Services
  • 7.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 7.9.1. Hospitals
    • 7.9.2. Ambulatory Surgical Centers
    • 7.9.3. Diagnostic Centers
    • 7.9.4. Homecare Settings
    • 7.9.5. Long Term Care Centers
    • 7.9.6. Emergency Medical Services
  • 7.10. Drivers and Restraints: Impact Analysis
  • 7.11. Market Attractiveness Analysis
    • 7.11.1. By Country
    • 7.11.2. By Product Type
    • 7.11.3. By Application
    • 7.11.4. By End User
  • 7.12. Key Representative Market Participants
  • 7.13. Key Participants Market Presence (Intensity Map)

8. Middle East and Africa (MEA) Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 8.2.1. GCC Countries
    • 8.2.2. South Africa
    • 8.2.3. Rest of MEA
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 8.3.1. GCC Countries
    • 8.3.2. South Africa
    • 8.3.3. Rest of MEA
  • 8.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 8.4.1. Implantable Cardiac Monitors
    • 8.4.2. Resting ECG Devices
    • 8.4.3. ECG Stress Test Devices
    • 8.4.4. Mobile Cardiac Telemetry Monitors
    • 8.4.5. Holter Monitors
  • 8.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 8.5.1. Implantable Cardiac Monitors
    • 8.5.2. Resting ECG Devices
    • 8.5.3. ECG Stress Test Devices
    • 8.5.4. Mobile Cardiac Telemetry Monitors
    • 8.5.5. Holter Monitors
  • 8.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 8.6.1. Atrial Fibrillation
    • 8.6.2. Bradycardia
    • 8.6.3. Conduction Disorders
    • 8.6.4. Premature Contraction
    • 8.6.5. Tachycardia
    • 8.6.6. Ventricular Fibrillation
    • 8.6.7. Others
  • 8.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 8.7.1. Atrial Fibrillation
    • 8.7.2. Bradycardia
    • 8.7.3. Conduction Disorders
    • 8.7.4. Premature Contraction
    • 8.7.5. Tachycardia
    • 8.7.6. Ventricular Fibrillation
    • 8.7.7. Others
  • 8.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 8.8.1. Hospitals
    • 8.8.2. Ambulatory Surgical Centers
    • 8.8.3. Diagnostic Centers
    • 8.8.4. Homecare Settings
    • 8.8.5. Long Term Care Centers
    • 8.8.6. Emergency Medical Services
  • 8.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 8.9.1. Hospitals
    • 8.9.2. Ambulatory Surgical Centers
    • 8.9.3. Diagnostic Centers
    • 8.9.4. Homecare Settings
    • 8.9.5. Long Term Care Centers
    • 8.9.6. Emergency Medical Services
  • 8.10. Drivers and Restraints: Impact Analysis
  • 8.11. Market Attractiveness Analysis
    • 8.11.1. By Country
    • 8.11.2. By Product Type
    • 8.11.3. By Application
    • 8.11.4. By End User
  • 8.12. Key Representative Market Participants
  • 8.13. Key Participants Market Presence (Intensity Map)

9. Competition Landscape

  • 9.1. Market Structure
  • 9.2. Competition Dashboard
  • 9.3. Company Profiles (Details - Overview, Financials, Strategy, SWOT, Recent Developments)
    • 9.3.1. NUUBO Smart Solutions Technologies, SL
    • 9.3.2. Koninklijke Philips N.V.
    • 9.3.3. GE Healthcare (General Electric Company)
    • 9.3.4. Welch Allyn - A Hill-Rom Inc. Company
    • 9.3.5. Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
    • 9.3.6. Nihon Kohden Corporation
    • 9.3.7. Fukuda Denshi Co., Ltd.
    • 9.3.8. Biotelemetry, Inc.
    • 9.3.9. AliveCor, Inc.
    • 9.3.10. Biotronik, Inc.
    • 9.3.11. Medronic, Plc.
    • 9.3.12. St. Jude Medical, LLC. (Abbott Laboratories)

10. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size Analysis 2019-2023, By Region
    • 10.2.1. North America
    • 10.2.2. Latin America
    • 10.2.3. Europe
    • 10.2.4. Asia Pacific (APAC)
    • 10.2.5. Middle East and Africa (MEA)
  • 10.3. Market Size Analysis 2024-2031, By Region
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. Asia Pacific (APAC)
    • 10.3.5. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Product Type

  • 11.1. Introduction/Key Findings
  • 11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2019-2023
    • 11.2.1. Implantable Cardiac Monitors
    • 11.2.2. Resting ECG Devices
    • 11.2.3. ECG stress Test Devices
    • 11.2.4. Mobile Cardiac Telemetry Monitors
    • 11.2.5. Holter Monitors
  • 11.3. Market Size (US$ Mn) and Volume and Forecast By Product Type, 2024-2031
    • 11.3.1. Implantable Cardiac Monitors
    • 11.3.2. Resting ECG Devices
    • 11.3.3. ECG stress Test Devices
    • 11.3.4. Mobile Cardiac Telemetry Monitors
    • 11.3.5. Holter Monitors
  • 11.4. Market Attractiveness Analysis By Product Type

12. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Application

  • 12.1. Introduction/Key Findings
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2019-2023
    • 12.2.1. Atrial Fibrillation
    • 12.2.2. Bradycardia
    • 12.2.3. Conduction Disorders
    • 12.2.4. Premature Contraction
    • 12.2.5. Tachycardia
    • 12.2.6. Ventricular Fibrillation
    • 12.2.7. Others
  • 12.3. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 12.3.1. Atrial Fibrillation
    • 12.3.2. Bradycardia
    • 12.3.3. Conduction Disorders
    • 12.3.4. Premature Contraction
    • 12.3.5. Tachycardia
    • 12.3.6. Ventricular Fibrillation
    • 12.3.7. Others
  • 12.4. Market Attractiveness Analysis By Application

13. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By End User

  • 13.1. Introduction/Key Findings
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 13.2.1. Hospitals
    • 13.2.2. Ambulatory Surgical Centers
    • 13.2.3. Diagnostic Centers
    • 13.2.4. Homecare Settings
    • 13.2.5. Long Term Care Centers
    • 13.2.6. Emergency Medical Services
  • 13.3. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 13.3.1. Hospitals
    • 13.3.2. Ambulatory Surgical Centers
    • 13.3.3. Diagnostic Centers
    • 13.3.4. Homecare Settings
    • 13.3.5. Long Term Care Centers
    • 13.3.6. Emergency Medical Services
  • 13.4. Market Attractiveness Analysis By End User

14. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Market Size and Y-o-Y Growth
  • 14.2. Absolute $ Opportunity

15. Assumptions and Acronyms Used

16. Research Methodology